What happens when you stop
The two innovators
This recognition is important because it: Legitimizes the disease as a genuine health problem, not merely an aesthetic concern Justifies research into immunomodulatory treatments (such as JAK inhibitors approved in 2022) Explains the frequent association with other autoimmune diseases (Hashimoto's thyroiditis, type 1 diabetes, alopecia areata, rheumatoid arthritis) Some figures Vitiligo affects approximately 0.5 to 2% of the global population , or nearly 1 person in 100
With those deadlines set, many pharmacies and compounding facilities did wind down their GLP-1 compounding operations
The MHRA, which is responsible for evaluating the safety, quality, and efficacy of medicines in the UK, has not licensed retatrutide for any indication
LeeNKSowaHHinoiEFerronMAhnJDConfavreuxCet al